Results 41 to 50 of about 45,555 (245)

The radiobiology of radiosurgery and stereotactic radiotherapy

open access: yesMedical Dosimetry, 1998
Radiation therapy has evolved into a complex amalgamation of treatment techniques that differ significantly according to the way the radiation is delivered to the patient and coincidentally according to the biologic effects that are observed with each technique.
Departments of Radiation Oncology and Neurosurgery, University of Florida College of Medicine, Gainesville, FL 32610, USA ( host institution )   +4 more
openaire   +3 more sources

Stereotactic radiotherapy for adrenal oligometastases

open access: yesReports of Practical Oncology and Radiotherapy, 2022
Approximately 50% of melanomas, 30-40% of lung and breast cancers and 10-20% of renal and gastrointestinal tumors metastasize to the adrenal gland. Metastatic adrenal involvement is diagnosed by computed tomography (CT ) with contrast medium, ultrasound (which does not explore the left adrenal gland well), magnetic resonance imaging (MRI) with contrast
Borghesi S.   +4 more
openaire   +4 more sources

A frameless method for stereotactic radiotherapy

open access: yesThe British Journal of Radiology, 1993
Abstract A frameless method for stereotactic multiple arc radiotherapy (SMART) is described. Three short gold wires are implanted in the scalp approximately 100 mm apart. These are localized in a computed tomographic or angiographic study along with the target.
D, Jones   +6 more
openaire   +2 more sources

Stereotactic Radiotherapy for Trigeminal Schwannomas [PDF]

open access: yesNeurosurgery, 2012
Data on radiotherapy for trigeminal schwannomas (TSs) and comparison of stereotactic radiosurgery (SRS) with fractionated stereotactic radiotherapy (FSRT) are limited.We present a large retrospective review of our institutional experience treating TSs with SRS and FSRT.
Colin E, Champ   +6 more
openaire   +2 more sources

Intrapatient tumour heterogeneity and clonal evolution in an autopsy study of metastatic salivary gland cancer

open access: yesMolecular Oncology, EarlyView.
Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche   +10 more
wiley   +1 more source

Elimination of refractory ventricular tachycardia storm and fibrillation using stereotactic radiotherapy

open access: yesClinical Case Reports, 2023
Ventricular tachycardia storm is a potentially lethal condition with limited treatment options. Failed ablation is associated with a fourfold mortality increase in this population. Stereotactic body radiotherapy was proposed in these cases.
Alexander Wutzler   +4 more
doaj   +1 more source

Dactolisib outperforms Rapamycin in potentiating apoptosis induced by XPO1, Bcl‐2 and Mcl‐1 blockade in preclinical glioblastoma models

open access: yesFEBS Open Bio, EarlyView.
The PAM pathway and its impact on cellular metabolism. Color‐coded key symbols represent Rapamycin (R, orange, targeting mTOR) and Dactolisib (D, green, targeting PI3K/mTOR), indicating their sites of action. Created with BioRenders.com. Glioblastoma resists therapy through interconnected survival programs.
Kai Zhao   +23 more
wiley   +1 more source

Stereotactic radiotherapy for lung oligometastases

open access: yesReports of Practical Oncology and Radiotherapy, 2022
30-60% of cancer patients develop lung metastases, mostly from primary tumors in the colon-rectum, lung, head and neck area, breast and kidney. Nowadays, stereotactic radiotherapy (SRT ) is considered the ideal modality for treating pulmonary metastases.
Falcinelli L.   +9 more
openaire   +2 more sources

Chemotherapy‐Activated GSK3β‐DNMT1 Signaling Upregulates CD47 to Evade Macrophage Phagocytosis and Drive Temozolomide Resistance in Glioblastoma

open access: yesAdvanced Science, EarlyView.
Temozolomide treatment activates GSK3β, driving DNMT1 phosphorylation, destabilization, and CD47 promoter hypomethylation in glioblastoma. This epigenetic shift upregulates CD47, enabling TMZ‐treated GBM cells to evade macrophage phagocytosis, survive chemotherapy, and acquire resistance.
Jie Li   +11 more
wiley   +1 more source

Stereotactic radiotherapy for bone oligometastases

open access: yesReports of Practical Oncology and Radiotherapy, 2022
About 60-90% of cancer patients are estimated to develop bone metastases, particularly in the spine. Bone scintigraphy, computed tomography (CT ) and magnetic resonance imaging (MRI ) are currently used to assess metastatic bone disease; positron emission tomography/computed tomography (PET-CT ) has become more widespread in clinical practice because ...
Colosimo C.   +13 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy